Pharmaceuticals Market Research Reports & Industry Analysis
Filter your search
Research Assistance
Pharmaceuticals Industry Research & Market Reports
-
United States Pain Management Therapeutics Market, Patients Volume, and 50 Company’s Pipeline Analysis (By Product, Indication, Phase of Development)
...companies, as they continue their efforts to maintain significant growth margins by tapping into markets of major unmet medical needs. United States Pain Therapeutics market persists with regular developments and discoveries of new drugs addressing ... Read More
-
Europe Cancer Biomarker Market Forecast 2017-2025
...to increase to up to $8646 million by the end of this forecast period. MARKET INSIGHTS The European market has a huge opportunity to grow in personalized medication on account of the support generated for ... Read More
-
Global Cancer Biomarker Market Forecast 2017-2025
...end of 2025. Some of the important drivers for the global biomarker market include encouragement by the FDA for biomarker development, the adoption of western lifestyles in developing countries, heavy investments by government and private ... Read More
-
Global Cognitive Assessment & Training Market By Component (Solutions Vs. Services), By Assessment Type (Pen & Paper, Online & Biometric), By End User (Healthcare, Education & Others), By Region, Competition Forecast & Opportunities, 2012 – 2022
...– 2022 Global cognitive assessment & training market is projected to reach $9.48 billion by the end of 2022. Growth is expected to be driven by several factors including rising adoption of cognitive assessment & ... Read More
-
Global Vaccines Market & Forecast (14 Vaccines Market, Number of People Immunized Doses of Vaccines Administered)
...dominant market share compared to Adult vaccines market. By 2022 Pediatric vaccines market share will be double the size of adult vaccines market share. Worldwide the number of infants immunized by influenza vaccines remain considerably ... Read More
-
Global Graft vs Host Disease (GVHD) Treatment Market 2017-2021
...immunity. GVHD is an induced indication and emerges post organ or tissue transplant. The probability of developing GVHD is higher in allogeneic transplant, a transplant where donor's organ/cell are used for transplantation compared with autologous ... Read More
-
Biopsy Devices Market by Product (Core Needle Biopsy, Aspiration Biopsy, Vacuum Assisted Biopsy) Application (Breast Biopsy, Lung Biopsy, Prostate Biopsy) Guidance (Stereotactic, Ultrasound) & by End User (Hospital) - Global Forecast to 2022
...global biopsy devices market is projected to grow at a CAGR of 6.8%.” The global biopsy devices market is projected to reach USD 2.42 billion by 2022 from USD 1.74 billion in 2017, at a ... Read More
-
Asia-pacific Cancer Biomarker Market 2017-2025
...is the fastest growing market in the Asia-Pacific region. MARKET INSIGHTS The market is mainly categorized into diseases and discovery & diagnostics, and further into their sub-segments. The adoption of western lifestyles in developing Asia ... Read More
-
North America Cancer Biomarker Market Forecast 2017-2025
...forecasted years of 2017-2025. The market collections are also predicted to increase from $3748 million in 2016 to $11420 million by 2025. MARKET INSIGHTS The market is mainly segmented into two segments: discovery& diagnostics and ... Read More
-
Animal Model Services Global Market - Forecast to 2025
...every medical breakthrough in human and animal health has been the result of research using animals. Animals in research are essential for the development of new and more effective methods for diagnosis and treatment of ... Read More
-
Chemical and Pharmaceutical Plants (Construction) in Poland: Market Analytics by Category & Cost Type to 2021
...contains historic and forecast market data for the chemical and pharmaceutical plants category in Poland, it also provides detailed breakdown of the data by construction activity (new construction, repair and maintenance, refurbishment and demolition) and ... Read More
-
Global Epigenetics Market 2017-2021
...silent genes are often associated with inaccessible chromatin regions. Epigenetics products that include reagents, kits, enzymes, instruments, and drugs help in analyzing epigenetic changes on the basis of which epigenetic therapy develops. Technavio’s analysts forecast ... Read More
-
Global Pediatric Proton Therapy Market & Forecast (10 Countries Market Data), Patients Treated
...The efficiency of proton therapy continues to add trust of Pediatric cancer patients globally. The course of action is known for successfully destructing tumor cells by damaging their DNA during a targeted deposition of high-energy ... Read More
-
USA Insulin Pump Market & Users, CGM (Continuous Glucose Monitoring) Market & Users, Reimbursement Policy (By States), Diabetes (Type1 & 2) Population, Deal Types, Clinical Trials & Forecast
...to cross US$ 5 Billion by end of the year 2022. Insulin Pump has now become a well-known and a favored device for Type1 diabetes patients in the United States. The easiness of using insulin ... Read More
-
Global Urinary Tract Infection Treatment Market 2017-2021
...tract. UTI can be classified into different types depending on the portion of the urinary system affected. Women are comparatively at a higher risk of developing UTI as compared with men since the urethra of ... Read More
-
Bahrain Pharmaceuticals and Healthcare Report Q4 2017
...health insurance scheme in the coming years, coupled with a rising chronicdisease burden. However, Bahrain's small population and unfavourable risk profile will continue to limitmultinational drugmakers' interest in the market. Headline Expenditure Projections Pharmaceuticals: BHD148mn ... Read More
-
Ecuador Pharmaceuticals and Healthcare Report Q4 2017
...Healthcare service provision in Ecuador will continue to improve steadily, and opportunities for privatesector growth will be supported by the rise in medical tourism. Headline Expenditure Projections Pharmaceuticals: USD1.68bn in 2016 to USD1.78bn in 2017; ... Read More
-
Global Acute Ischemic Stroke Therapeutics Market 2017-2021
...loss of neurological function. AIS is caused by thrombotic or embolic obstruction of the cerebral artery and is more common than hemorrhagic stroke. The global AIS therapeutics market is expected to register a low single ... Read More
-
Global Cancer Gene Therapy Market 2017-2021
...the individual's body. It can be used for both the prevention and treatment of disease. The major therapies used for the treatment are oncolytic virotherapy, gene transfer, and gene-induced immunotherapy. The rising prevalence rate of ... Read More
-
Global Sphygmomanometer Market 2017-2021
...monitored in addition to BP from a single device. The most commonly monitored parameters are body temperature, blood glucose, and BP. People use these monitoring devices in their day-to-day life and does not require a ... Read More
-
Global Pharmaceutical Logistics Market 2017-2021
...other related logistics functions. As some of the pharmaceutical products are temperature sensitive, cold storage is required throughout the supply chain to maintain the quality of the products. Pharmaceutical manufacturers, the only customer segment of ... Read More
-
Global Melatonin Supplements Market 2017-2021
...commonly as oral medications. They are made from different biochemical compositions such as plants or animals. These supplements are available in various formulations such as melatonin tablets, capsules, lozenges, liquid melatonin, spray, drops, and sublingual ... Read More
-
Cameroon Pharmaceuticals and Healthcare Report Q4 2017
...Africa region. That said, low spending per capita onmedicine and an underdeveloped healthcare system will continue to weigh on the sector's potential. We alsohighlight that political risks derived from the 2018 presidential election have the ... Read More
-
Cuba Pharmaceuticals and Healthcare Report Q4 2017
...prevent a significant uptick in investmentinterest, given the subdued operating environment. While Cuba's ageing population and rising chronicdisease burden will support sustained pharmaceutical spending growth over the forecast period, domesticdrug production will continue to account ... Read More
-
Vietnam Pharmaceuticals and Healthcare Report Q4 2017
...insurance coverage andeconomic development. Nevertheless, challenges continue to be posed by insufficient distribution networksand a weak intellectual property environment. Headline Expenditure Projections Pharmaceuticals: VND106trn (USD4.7bn) in 2016 to VND119trn (USD5.2bn) in 2017; +13% in localcurrency ... Read More
